Number of Shares
421,724.00
Current Holdings Value*
$12.45 Mil
% of Portfolio
9.29%
Total Estimate Gain
$-5.06 Mil
% of Total Estimate Gain
-10.91%

ALETHEA CAPITAL MANAGEMENT, LLC's Avidity Biosciences Inc Holding Summary

As of 2025-03-31, ALETHEA CAPITAL MANAGEMENT, LLC held 421,724.00 shares of Avidity Biosciences Inc(RNA), totaling $12.45 Mil. This investment constitutes 9.29% of their stock portfolio, and ALETHEA CAPITAL MANAGEMENT, LLC now holds 0.35% of the outstanding Avidity Biosciences Inc(RNA) stock.

The initial trade took place in 2020Q4. And since then ALETHEA CAPITAL MANAGEMENT, LLC has made 5 purchases of RNA, at an average price of $29.00, for a total of 1.60 Mil shares. In addition, there have been 10 sales at an average price of $24.64 for 1.18 Mil shares. Based on historical transaction data and RNA's current price of $29.17, ALETHEA CAPITAL MANAGEMENT, LLC's estimated gain on his RNA holdings is $-5.06 Mil, reflecting a -10.91% gain to date.

ALETHEA CAPITAL MANAGEMENT, LLC RNA ($29.17) Holding Chart

ALETHEA CAPITAL MANAGEMENT, LLC RNA ($29.17) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1